Victory Capital Management Inc. Buys 13,802 Shares of DaVita Inc. (NYSE:DVA)

Victory Capital Management Inc. increased its stake in DaVita Inc. (NYSE:DVA - Free Report) by 31.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,074 shares of the company's stock after purchasing an additional 13,802 shares during the period. Victory Capital Management Inc. owned approximately 0.07% of DaVita worth $8,731,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of DVA. Invesco Ltd. raised its position in shares of DaVita by 20.9% in the 4th quarter. Invesco Ltd. now owns 1,589,545 shares of the company's stock valued at $237,716,000 after buying an additional 275,284 shares in the last quarter. Northern Trust Corp increased its stake in DaVita by 12.5% in the fourth quarter. Northern Trust Corp now owns 740,774 shares of the company's stock valued at $110,783,000 after acquiring an additional 82,326 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in DaVita by 14.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock valued at $69,697,000 after purchasing an additional 57,386 shares in the last quarter. Deutsche Bank AG lifted its stake in DaVita by 35.2% during the fourth quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock worth $58,687,000 after purchasing an additional 102,230 shares during the last quarter. Finally, Epoch Investment Partners Inc. acquired a new stake in shares of DaVita in the 4th quarter valued at $55,100,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on DVA shares. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Truist Financial dropped their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, DaVita currently has a consensus rating of "Hold" and a consensus price target of $167.40.

Insider Activity

In other DaVita news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

DaVita Stock Up 0.2%

Shares of DVA stock traded up $0.26 on Friday, reaching $145.03. 524,535 shares of the company were exchanged, compared to its average volume of 775,886. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The company has a 50-day moving average of $140.31 and a 200-day moving average of $148.37. The company has a market cap of $10.95 billion, a price-to-earnings ratio of 14.37, a PEG ratio of 1.00 and a beta of 1.11. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.26 earnings per share. Analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.